ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
47.87
Bid
47.87
Ask
47.91
Volume
51,223
47.15 Day's Range 48.075
0.00 52 Week Range 0.00
Previous Close
46.93
Open
47.20
Last Trade Time
Average Volume (3m)
-
Financial Volume
$ 2,440,597
VWAP
47.6465

SBIO Latest News

IVZ Nasdaq Biotech UCITS ETF$ Net Asset Value(s)

IVZ Nasdaq Biotech UCITS ETF$ 25 November 2024   FUND: Invesco NASDAQ Biotech UCITS ETF DEALING DATE: 22-Nov-24 NAV PER SHARE: USD:46.9751 NUMBER OF SHARES IN ISSUE: 6,635,592.00 CODE: SBIO...

IVZ Nasdaq Biotech UCITS ETF$ Net Asset Value(s)

IVZ Nasdaq Biotech UCITS ETF$ 22 November 2024   FUND: Invesco NASDAQ Biotech UCITS ETF DEALING DATE: 21-Nov-24 NAV PER SHARE: USD:46.263 NUMBER OF SHARES IN ISSUE: 6,635,592.00 CODE: SBIO...

IVZ Nasdaq Biotech UCITS ETF$ Net Asset Value(s)

IVZ Nasdaq Biotech UCITS ETF$ 21 November 2024   FUND: Invesco NASDAQ Biotech UCITS ETF DEALING DATE: 20-Nov-24 NAV PER SHARE: USD:45.9449 NUMBER OF SHARES IN ISSUE: 6,598,592.00 CODE: SBIO...

IVZ Nasdaq Biotech UCITS ETF$ Net Asset Value(s)

IVZ Nasdaq Biotech UCITS ETF$ 20 November 2024   FUND: Invesco NASDAQ Biotech UCITS ETF DEALING DATE: 19-Nov-24 NAV PER SHARE: USD:45.6098 NUMBER OF SHARES IN ISSUE: 6,833,592.00 CODE: SBIO...

IVZ Nasdaq Biotech UCITS ETF$ Net Asset Value(s)

IVZ Nasdaq Biotech UCITS ETF$ 19 November 2024   FUND: Invesco NASDAQ Biotech UCITS ETF DEALING DATE: 18-Nov-24 NAV PER SHARE: USD:45.4619 NUMBER OF SHARES IN ISSUE: 6,850,992.00 CODE: SBIO...

IVZ Nasdaq Biotech UCITS ETF$ Net Asset Value(s)

IVZ Nasdaq Biotech UCITS ETF$ 18 November 2024   FUND: Invesco NASDAQ Biotech UCITS ETF DEALING DATE: 15-Nov-24 NAV PER SHARE: USD:45.5721 NUMBER OF SHARES IN ISSUE: 6,870,992.00 CODE: SBIO...

IVZ Nasdaq Biotech UCITS ETF$ Net Asset Value(s)

IVZ Nasdaq Biotech UCITS ETF$ 15 November 2024   FUND: Invesco NASDAQ Biotech UCITS ETF DEALING DATE: 14-Nov-24 NAV PER SHARE: USD:47.6897 NUMBER OF SHARES IN ISSUE: 6,898,992.00 CODE: SBIO...

IVZ Nasdaq Biotech UCITS ETF$ Net Asset Value(s)

IVZ Nasdaq Biotech UCITS ETF$ 14 November 2024   FUND: Invesco NASDAQ Biotech UCITS ETF DEALING DATE: 13-Nov-24 NAV PER SHARE: USD:48.8431 NUMBER OF SHARES IN ISSUE: 6,914,492.00 CODE: SBIO...

IVZ Nasdaq Biotech UCITS ETF$ Net Asset Value(s)

IVZ Nasdaq Biotech UCITS ETF$ 13 November 2024   FUND: Invesco NASDAQ Biotech UCITS ETF DEALING DATE: 12-Nov-24 NAV PER SHARE: USD:49.2355 NUMBER OF SHARES IN ISSUE: 6,914,492.00 CODE: SBIO...

IVZ Nasdaq Biotech UCITS ETF$ Net Asset Value(s)

IVZ Nasdaq Biotech UCITS ETF$ 12 November 2024   FUND: Invesco NASDAQ Biotech UCITS ETF DEALING DATE: 11-Nov-24 NAV PER SHARE: USD:50.5643 NUMBER OF SHARES IN ISSUE: 6,882,492.00 CODE: SBIO...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ZENAZenaTech Inc
$ 6.42
(258.66%)
116.31M
QMCOQuantum Corporation
$ 21.67
(137.35%)
30.84M
SMTKSmartKem Inc
$ 5.50
(71.88%)
3.16M
INVZWInnoviz Technologies Ltd
$ 0.085
(70.00%)
152.17k
RGTIRigetti Computing Inc
$ 2.75
(58.05%)
270.55M
SAVACassava Sciences Inc
$ 4.295
(-83.78%)
91.09M
ONCTOncternal Therapeutics Inc
$ 0.73
(-35.96%)
775.64k
CRKNCrown Electrokinetics Corporation
$ 0.4246
(-35.43%)
12.6M
HTLMHomesToLife Ltd
$ 2.60
(-34.59%)
212.64k
AMPGAmplitech Group Inc
$ 0.92
(-25.81%)
646.34k
NVDANVIDIA Corporation
$ 136.02
(-4.18%)
335.23M
ELABElevai Labs Inc
$ 0.0157
(-21.89%)
322.53M
RGTIRigetti Computing Inc
$ 2.75
(58.05%)
267.78M
SMCISuper Micro Computer Inc
$ 38.42
(15.90%)
166.84M
CTXRCitius Pharmaceuticals Inc
$ 0.1337
(-0.07%)
141M

Discussion

View Full Feed
sortagreen sortagreen 3 minutes ago
I served. My cousins served. My father was at Leyte, Lingayen and everything else up to Tokyo Bay. His brothers served (3 wars each). My grandfather was in the trenches in WWI.

You are a punk and a piece of filth.

I've never been ashamed to be an American or a soldi
WooptdooU WooptdooU 3 minutes ago
Misguider lebby is not even that respected by THE NEW BOD MEMBERS...take that and chew on it...I am not referring to titsy...that one loves it.
LWLG
MJAM2020 MJAM2020 4 minutes ago
I'm ready for the Billion + volume day. If FOXO can do it with a tiny float and a price around .50 then I would imagine RNVA could easily that kind of volume when a good push occurs.

imho
mj
FOXO RNVA
RobotDroid RobotDroid 5 minutes ago
Somethings been wrong for a long time.
NWBO
waterchaser waterchaser 5 minutes ago
Or not.
Lmao. DJT will continue to be a money maker for many.
https://investorshub.advfn.com/uimage/uploads/2019/10/19/pvnwsFF6035D1-2071-45DA-9726-5209187FFA0A.jpeg
DJT
MartinLutherKing MartinLutherKing 6 minutes ago
FDA green light RNAZ explosion coming brothers Live the dream
RNAZ
NeutrinoKid NeutrinoKid 6 minutes ago
The whole point of the lipid nanoparticles is to support the ampakine program, and resolve their constitutive problem with delivery and targeting. Dronabinol is just a means to that end.
RSPI
MartinLutherKing MartinLutherKing 8 minutes ago
SAVA Hold the line brothers RNAZ Green light cancer cure is coming get it all back
RNAZ
MysticSphinx18 MysticSphinx18 8 minutes ago
I didn't realize that. So you can't buy it on some platforms? I"m on Etrade and I've been able to buy this whole time.
CGAC
Acme Investments Acme Investments 8 minutes ago
Take a look at Sinc Twitter feed!! This is what happens when you believe in Santa!! People take advantage of you!! No retail individuals can manipulate the market!!
SINC
I ll be back I ll be back 8 minutes ago
Makes them a no brainer for a RS.

The A/S is maxed out and management hasn't yet disclosed how they intend to raise capital with no new shares to sell. Does anyone seriously believe management put tens of millions in assets into a public company in which they own no shares? Does anyon
SPZI
DCBill DCBill 8 minutes ago
Never forget, when it comes to F&F, "the government lies." I hope it doesn't this time.
FNMA
theorysuit theorysuit 9 minutes ago
Look at these apologists coming out now and saying this is normal and now even pushing q2 2025. They were bashing me when I said back in January it would be about a year based on vrtx and crsp.
NWBO
bull runs bull runs 9 minutes ago
Amazing how so many keep making claims about DJT hitting pennies. Like so many other scandalous theories all they need is MORE time. Lmao. DJT will continue to be a money maker for many. It WILL NOT be going anywhere near penny land. Lmao
DJT
sortagreen sortagreen 10 minutes ago
Were they asleep during the Obama administration?

Biden's old and he still believed there was a country left to salvage. That's all I can think. He got the Infrastructure Bill and the Chips and Science Bill... but he made a lot of mistakes in thinking that right makes right. It do
Involuntary-Recluse Involuntary-Recluse 10 minutes ago
Typhoon Trump laying down the tariffs :-)

MAGA MAHA

https://investorshub.advfn.com/uimage/uploads/2024/11/25/lhwbiYesThumbsGIF.gif
Mr. C Mr. C 11 minutes ago
Financing likely won’t move until permits are in hand. Nothing to do, but wait.

Looks like some are accumulating in the meantime
TGLO
delerious1 delerious1 11 minutes ago
and what do you base it on.... and what happens to XRP between now and Jan 20 ??
XRPUSD
BakedLangostino BakedLangostino 11 minutes ago
And how long would it take to find 250+ rare disease patients? Remember that Daybue, while not perfect, was available and being recommended and Blarcamesine trial patients weren't allowed to take Daybue. So the decision to enroll in an experimental trial was not one that everyone flocked to, and it
AVXL
The Night Stalker The Night Stalker 12 minutes ago
NICE
MNTR
GLee17 GLee17 12 minutes ago
Can’t imagine getting fins posted, then saying nothing. 10 days after and quite as a mouse.
MVNT
weedtrader420 weedtrader420 12 minutes ago
XRP📈HOUSE OF PAIN - JUMP AROUND
XRPUSD
Hoskuld Hoskuld 13 minutes ago
That would be a journal with a very low impact factor - let's hope they do better than that.
AVXL
IanFromSI IanFromSI 13 minutes ago
If you look at his most recent track record that has been analyzed completely (for the year, 2018), His track record is atrocious.

Investors would’ve done much better to stay in cash then to get the -7.18% return of his recommendations.

Included Was a bearish outlook f
NVDA
Stinger2014 Stinger2014 14 minutes ago
So we have to wait some more? lol $WAIT will be our new symbol (never gets old),
WAIT

Your Recent History

Delayed Upgrade Clock